NICE Diagnostics Advisory Committee members
Professor Adrian Newland CBE
Professor Newland has been a Consultant Haematologist at Barts and the London NHS Trust for almost 30 years, and Professor of Haematology at Queen Mary's School of Medicine and Dentistry (Barts and the London), since 1995. He is Director of Pathology for the Trust. He takes up his position as Chair having already held a number of high-profile positions, including President of the Royal College of Pathologists (2005 - 2008), and Director of the North East Thames Cancer Network (2001 - current), amongst many others. Professor Newland also chaired the London Cancer New Drugs Group, which has a remit to review drugs that have not yet been through the NICE assessment process.
Professor Ron Akehurst
Dean - School of Health and Related Research (ScHARR) at the Sheffield University
Ron Akehurst is Dean of ScHARR, a major centre for Health Services Research in Europe with some 200 staff, and is Professor of Health Economics. ScHARR is a major supplier of analytical services to NICE, including assessment reports, evidence reviews, and decision support for the development of clinical guidelines and Interventional Procedures guidance.
His interests are primarily in Health Technology Assessment (HTA) and he has published widely in that area. He has had some involvement in developing HTA processes in other countries, including Hungary and Korea. Ron was a founding member of the National Institute for Clinical Excellence (NICE) Appraisal Committee, serving on it for 7 years; and has also served on the NICE Topic Selection Committee and the NICE Public Health Interventions Advisory Committee.
Past activities include a 2 year period as an Economic Advisor to the Department of Health and as a Specialist Advisor to the Parliamentary House of Commons Health Select Committee for 3 years. Ron spent 3 years as a Non-Executive Director of a Health Authority, responsible for commissioning Health Services.
Dr Trevor Cole MB, ChB, FRCP
Consultant Clinical Geneticist at the Birmingham Women's Hospital Foundation Trust
Trevor Cole specialised in clinical genetics after training in adult medicine and paediatrics and was appointed to the above post in 1992.
As lead for cancer genetics services in the 1990's he developed and implemented clinical pathways for the management of inherited cancers and integrated molecular testing to improve the efficacy of management. Appointed as clinical lead for clinical genetics, this remit was expanded to include integration of medical genetics into a wide range of mainstream specialities. This pilot work was supported by a department of health grant following the 2003 government white paper on medical genetics. Trevor's clinical interests now lie mostly in the areas of translational research and the introduction of new genetic technologies into mainstream practice.
Trevor is Chair of the Joint Royal Colleges Committee for Medical Genetics (JCMG); and sits on the UK Genetic Testing Network (UKGTN) working group on commissioning laboratory genetics, and also the National Commissioning Group.
Dr Paul O Collinson MA, MB, BChir, FRCPath, MD
Consultant Chemical Pathologist to St George's Hospital
Paul Collinson's clinical interests are in the management of Cardiovascular Risk and Research interest in the pathogenesis, diagnosis and management of acute coronary syndromes.
He has a special interest the cost economics of cardiac care, point of care testing and evidence based laboratory medicine and is clinical lead for the National Laboratory Medicine Catalogue.
Dr Sue Crawford MRCP MRCGP DipRCPath
General Practitioner in Devon
Dr Sue Crawford is a general practitioner with an interest in diagnostics and in improving the primary / secondary care working interface.
She has been a partner in a rural dispensing practice in the South Hams for the last 3 years.
During this time she has established the practice as part of the Primary Care Research Network. For 10 years prior to moving to Devon she combined roles as an Associate Specialist in Haematology in West Dorset with being an assistant to a single handed rural GP and GP educator for the Dorset GP training scheme. She now represents the practice on the local commissioning consortium.
Professor Ian Cree
Director of Efficacy and Mechanisms Programme at NETSCC
Ian Cree trained as a general pathologist and has a PhD in immunology. He has held posts as a consultant pathologist in Dundee, in London at the Institute of Ophthalmology, and in Portsmouth, where he is now Director of the Cancer Laboratory and Translational Oncology Research Centre. He has been responsible for the implementation of molecular diagnostic methods in pathology and has shown how these can benefit patient pathways.
Ian's research career has been based on investigating disease mechanisms and then acting on the information obtained to improve diagnosis or treatment. This has involved designing, conducting and leading clinical trials as well as a number of large multicentre studies. Ian's current research interests are mostly cancer-related (particularly predictive methods to allow individualised therapy of cancer), but his previous interests have included infectious disease, asthma, and ophthalmology.
In October 2008, he was appointed part-time Director of the NIHR Evaluation, Trials and Studies Coordinating Centre - Efficacy and Mechanisms Evaluation Programme, based at the University of Southampton.
Professor Erika Denton FRCP, FRCR
National Clinical Director for Imaging, Department of Health
Erika Denton is a radiologist in Norwich with a specific interest in Breast Imaging. She has chaired the Royal College of Radiologists Breast Group and been Divisional Clinical Director for support Services in Norwich.
In 2005 Erika was appointed as National Clinical Lead and subsequently National Clinical Director for Imaging at The Department of Health. She became Medical Director for PACS at Connecting for Health in 2007 and Senior Responsible Owner for PACS in 2010. As head of the Radiology Academy and Head of Training in Norwich from 2002-2005 Erika developed the complex infrastructure for this important new training facility. Her role in the Integrated Training Initiative also includes being editor of the breast modules of the e-learning component of the RITI project.
Erika is Honorary Professor of Radiology at the University of East Anglia. Her main areas of research interest are health care policy, computerised image evaluation, risk stratification in mammography, and role extension in radiography
Dr Simon Fleming MSc, MD, FRCPath
Consultant in Clinical Biochemistry and Metabolic Medicine, Royal Cornwall Hospital.
Simon Fleming is a Consultant in Clinical Biochemistry and Metabolic Medicine in Cornwall and Honorary Teacher at the Peninsula College of Medicine and Dentistry. He trained in London and Newcastle upon Tyne and has specialist interests in lipidology, diabetes, clinical nutrition and cardiovascular research.
He has previously worked as a reviewer for National Confidential Enquiry into Patient Outcome and Death (NCEPOD) and the HTA Diagnostics Programme.
Professor Elizabeth (Lisa) A H Hall BSc, PhD, MA, FRSC
Professor of Analytical Biotechnology, Institute of Biotechnology in the Dept. of Chemical Engineering and Biotechnology, University of Cambridge.
Lisa Hall leads Cambridge Analytical Biotechnology and is Director of CamBridgeSens. A key area of her research is to link transduction technologies (electrochemistry, optics, ultrasound) with synthetic biology and nanomaterials to achieve sensors & diagnostic systems. Applications are highlighted by almost every initiative for health, environment, energy, security and quality of life in all parts of the developing and developed world.
She is a key driver in Analytical Biotechnology in Cambridge, and in facilitation of new interdisciplinary science, to maintain and increase an international profile in the field. She is co-founder of the CamBridgeSens initiative.
Professor Chris Hyde
Professor of Public Health & Clinical Epidemiology, Peninsula College of Medicine and Dentistry
Chris Hyde trained in medicine and public health in London and East Anglia respectively. His expertise is in systematic reviews and health technology assessments, particularly in the context of providing support to policy-makers. In this respect he has undertaken many reports for NICE, particularly it's Technology Appraisal Programme.
During his career he has set up and directed the Aggressive Research Intelligence Facility (ARIF), an effectiveness information support service for commissioners in the West Midlands. Chris has also directed the West Midlands Health Technology Assessment Collaboration and been closely involved with the Systematic Reviews Initiative of the National Blood Service. He has long-standing connections with the Cochrane Collaboration and is an editor of the NHS HTA Monograph series. He is currently based at the Peninsula College of Medicine and Dentistry where he leads the Technology Appraisal Group in PenTAG.
He has a long-standing interest in the evaluation of tests and has done health technology assessments on many topics including automated cervical screening, hysteroscopy, prediction of pre-eclampsia and pre-term birth, PET/CT, orthopantomography and identifying genetic sub-types in diabetes. He is currently part of the UK Support Unit for Cochrane Diagnostic Test Accuracy Reviews based at the University of Birmingham; and a member of the Cochrane Diagnostics Test Accuracy Editorial Board.
Professor Noor Kalsheker M.B, Ch.B, M.Sc, M.D, FRCPath
Professor of Clinical Chemistry, Molecular Medical Sciences, University of Nottingham
Noor Kalsheker works on the genetics of complex disease with a special interest in chronic obstructive pulmonary disease and alpha1-antitrypsin deficiency. He has worked in
several senior management positions including Head of School, Co-Director of the Institute of Genetics, University of Nottingham. He has served as the national Chair of the Scientific Committee of the Association of Clinical Biochemistry, Chair of the Academic Heads of Clinical Biochemistry.
Dr Mark Kroese MB, ChB, DPH, MRCGP, FFPH
Consultant in Public Health Medicine, PHG Foundation, Cambridge and UK Genetic Testing Network
Mark Kroese is a Consultant in Public Health Medicine at the PHG Foundation, Cambridge and was appointed Public Health Advisor to the UK Genetic Testing Network in 2006. Prior to working at the PHG Foundation, Mark worked for nearly 7 years as Consultant in Public Health Medicine at Peterborough Primary Care Trust.
His specialist interests are in the evaluation and regulation of genetic tests and the commissioning of clinical genetics services.
Dr Richard Nicholas
Consultant Neurologist at Heatherwood and Wexham Park Hospital, Imperial Healthcare Trust.
Richard Nicholas is a Consultant Neurologist at Heatherwood and Wexham Park Hospital, Imperial Healthcare Trust and is an Honorary Senior Lecturer at Imperial College.
He specialises in Multiple Sclerosis running a NHS disease modifying therapy clinic and helping to set up the NHS natalumizab infusion service at Imperial, currently the largest in the UK. He is a Trustee of the Multiple Sclerosis Trials Collaboration a charity aiming to facilitate access to new and emerging therapies for people with MS and he is clinical director of the UK Multiple Sclerosis Tissue Bank.
He is involved in pharmaceutical and academic clinical trials as well as basic science projects aiming to develop novel approaches to treatments, new trial designs and new methods of disease evaluation in Multiple Sclerosis.
Ms Margaret Ogden
Margaret Ogden works for a local authority in community development. She was formerly a member of the Patient And Public In Health Forum before it was abolished in 2008. She was a service user representative on the NICE Guideline Development Group for the treatment of depression in people with chronic physical health problems and found this a very positive and inclusive experience.
Margaret is currently a carer representative on a palliative care clinical studies group. Her other role is as one of 22 patient safety champions, working throughout England and Wales, in partnership with Strategic Health Authorities. She is also a peer reviewer for research proposals and lectures on patient safety at local universities.
Dr Diego Ossa MD, MSc
Global Head, Health Economics and Outcomes Research, Novartis Molecular Diagnostics
Diego Ossa heads the Health Economics And Outcomes Research Group at Novartis Molecular Diagnostics. Before assuming his current role, he held health economic positions in Novartis Global Development and in the UK organisation where he worked on the overall development and implementation of national guidance submission strategies for bodies such as NICE. His experience also includes several years in health economics consultancy.
Diego is a medical doctor with specialised training in clinical genetics, and he holds MSc. Degrees in Human Genetics and in Health Economics.
He is strong believer that molecular diagnostics can help physicians achieve better patient outcomes through personalised therapies, which can translate into improved health-care provision and better value-for-money alternatives.
Mr Stuart Saw
Director of Finance for North East London and City PCT's
Stuart Saw is the Director of Finance for North East London and City PCT's. Other senior roles include Deputy Director of Finance at the Public Health Laboratory Service HQ (PHLS), and Head of Business Planning and Contracts at the National Blood Service SE. He has worked in the NHS since 1987 and as a qualified accountant since 1991.
Professor Mark Sculpher BA (Hons), MSc, PhD
Professor of Health Economics, Centre for Health Economics, University of York
Mark Sculpher has worked in the field of economic evaluation and health technology assessment for over 20 years. He has researched in a range of clinical areas including heart disease and cancer. He has also contributed to methods in the field, in particular relating to decision analytic modelling and techniques to handle uncertainty. He has over 160 peer-reviewed publications and is a co-author of two major text books in the area.
Mark is a member of the UK National Institute of Health Research (NIHR) College of Senior Investigators. He has also been a member of the NICE Technology Appraisal and Public Health Interventions Advisory Committees. He chaired NICE's 2004 Task Group on methods guidance for economic evaluation; and has also advised health systems internationally on HTA methods including those in Ireland, Portugal and New Zealand. He has been a member of the Commissioning Board for the UK NHS Health Technology Assessment Programme and currently sits on the UK Medical Research Council's Methodology Research Panel.
Dr Steve Thomas MBBS, MRCP, FRCR, MSc
Consultant Vascular and Cardiac Radiologist at Sheffield Teaching Hospitals Foundation Trust.
Steve Thomas is a Consultant Cardiovascular Radiologist with expertise in diagnostic and interventional vascular radiology, and non- invasive assessment of cardiac disease using Cardiac Magnetic Resonance imaging and Computed Tomography. He is an Honorary Clinical Senior Lecturer at the University of Sheffield, where he has been carrying out Health Economic and Technology Appraisal research into new techniques/ technologies and diagnostics relevant to his clinical work.
Mr Paul Jerome Weinberger
CEO, DiaSolve Ltd, London
Paul Weinberger has a first degree in Pharmacology and an MBA from London Business School. He has twenty years experience in the healthcare industry, with the last fifteen dedicated to in vitro diagnostics.
Paul has served on the Executive Committee of BIVDA (British In Vitro Diagnostics Association) for eight years, including three spent as Chairman during which he led the industry's response to Lord Carter's review of NHS pathology services. He is currently Director of Clinical Development for Enigma Diagnostics, and previously led the Business Development function for Roche Diagnostics in the UK. His particular areas of expertise span research and development and market access, and he has first-hand experience of building evidence cases and health economic models.
Mr Christopher Wiltsher
Associate Lecturer for the Open University
Chris Wiltsher was a member of the Clinical Radiology Patients' Liaison Group of the Royal College of Radiologists for five years, terminating in August 2009. For the last four of those years he chaired the group, thus becoming involved ex officio in many aspects of the College's work. He was the lay lead in the development of the Imaging Services Accreditation Scheme, launched in June 2009. His career background is in adult education within higher education.
He is an Associate Lecturer for the Open University, teaching courses across a range of disciplines.
This page was last updated: 20 July 2012